大麻使用不影响减重手术结局
该研究在大型学术中心纳入2012至2017年1176例初次减重手术患者,按大麻使用分组,经倾向性评分匹配后各73对。结果显示大麻使用者在30天主要并发症及1年 excess BMI 下降上与对照组无差异,但2年随访率较低。结论提示大麻使用不应作为减重手术的禁忌证。
要点
- 大麻使用与减重术后30天主要并发症无显著差异。
- 大麻使用者在各时间点 excess BMI 下降与对照组无显著差异。
- 大麻使用者2年随访率显著低于对照组(12.3% vs 27.4%,p=0.023)。
核心结论
- 大麻使用对减重手术30天并发症和体重下降无显著影响,不应视为手术禁忌证。
研究设计与样本
- 在大型学术中心纳入2012至2017年1176例初次减重手术患者,排除19例失访。
- 采用倾向性评分匹配(基于术前年龄、性别、BMI和合并症)得到73对对照组和研究组。
- 所有患者术后随访两年。
主要发现
- 大麻使用者与对照组在3周(23.0% vs 18.9%,p=0.095)、3个月(42.0% vs 38.1%,p=0.416)、6个月(60.6% vs 63.1%,p=0.631)、1年(78.2% vs 77.3%,p=0.789)和2年(89.1% vs 74.5%,p=0.604)的 excess BMI 下降无显著差异。
- 两组在30天主要术后并发症(包括再入院、感染、血栓栓塞事件、出血事件和再手术率)上无差异。
- 大麻使用者2年随访率显著低于对照组(12.3% vs 27.4%,p=0.023)。
临床怎么用
- 大麻使用不应作为减重手术的禁忌证。
- 术前评估可正常考虑大麻使用者的减重手术指征。
- 需关注大麻使用者的术后随访依从性可能较低。
局限性
- 大麻使用者2年随访率显著低于对照组,可能影响远期结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The decriminalization of marijuana and legalization of derived products requires investigation of their effect on healthcare-related outcomes. Unfortunately, little data are available on the impact of marijuana use on surgical outcomes. We aimed to determine the effect of marijuana use on 30-day complications and 1-year weight loss following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG). METHODS: At a large academic center, 1176 consecutive patients undergoing primary bariatric surgery from 2012 to 2017 were identified and separated into cohorts according to marijuana use. The only exclusions were 19 patients lost to follow-up. Propensity score matching, using logistic regression according to preoperative age, gender, BMI, and comorbid conditions, yielded 73 patient pairs for the control and study arms. All patients were followed two years postoperatively. RESULTS: Excess BMI lost did not differ between marijuana users and controls at 3 weeks (23.0% vs 18.9%, p = 0.095), 3 months (42.0% vs 38.1%, p = 0.416), 6 months (60.6% vs 63.1%, p = 0.631), 1 year (78.2% vs 77.3%, p = 0.789), or 2 years (89.1% vs 74.5%, p = 0.604). No differences in the rate of major 30-day postoperative complications, including readmission, infection, thromboembolic events, bleeding events and reoperation rates, were found between groups. Follow-up rate at two years was lower in marijuana users (12.3% vs 27.4%, p = 0.023). CONCLUSION: This study suggests marijuana use has no impact on 30-day complications or weight loss following bariatric surgery, and should not be a contraindication to bariatric surgery.
引用
- Shockcor N, Adnan SM, Siegel A, et al. Marijuana use does not affect the outcomes of bariatric surgery. Surg Endosc. 2020. PMID: 32166550. doi:10.1007/s00464-020-07497-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。